Effect of continuous arteriovenous hemodiafiltration on the pharmacokinetics of fluconazole.
In critically ill patients with acute renal failure, continuous arteriovenous hemodiafiltration (CAVHD) has become an increasing popular supportive technique. An adult with acute renal failure during CAVHD therapy received fluconazole. Drug clearance by the hemodiafilter system and its total body clearance during the CAVHD period were 23-28 ml/minute and 22 ml/minute, respectively, indicating that the rate of systemic clearance was solely dependent on CAVHD in this patient. Total body clearance, area under the curve, and half-life values for this patient closely resembled those in healthy subjects. These observations suggest that patients treated with fluconazole during CAVHD should receive standard maintenance dosages, and neither supplementation nor dosage adjustment is required.
Nicolau
D P
DP
Department of Pharmacy, Hartford Hospital, Connecticut 06115.
Crowe
H
H
Nightingale
C H
CH
Quintiliani
R
R
D058186:Acute Kidney Injury / Q000378:metabolism* / Q000628:therapy; D000328:Adult; D015725:Fluconazole / Q000008:administration & dosage / Q000493:pharmacokinetics*; D006207:Half-Life; D017583:Hemodiafiltration; D006801:Humans; D008297:Male; D008657:Metabolic Clearance Rate
D015725:Fluconazole